Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
13,705,095
-
Share change
-
-221,006
-
Total reported value
-
$153,952,654
-
Price per share
-
$11.23
-
Number of holders
-
96
-
Value change
-
-$3,270,389
-
Number of buys
-
47
-
Number of sells
-
37
Institutional Holders of CONCERT PHARMACEUTICALS INC - COM (CNCE) as of Q2 2016
As of 30 Jun 2016,
CONCERT PHARMACEUTICALS INC - COM (CNCE) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,705,095 shares.
The largest 10 holders included
BVF INC/IL, SENZAR ASSET MANAGEMENT, LLC, BlackRock Fund Advisors, FRANKLIN RESOURCES INC, INGALLS & SNYDER LLC, Numeric Investors LLC, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, BlackRock Institutional Trust Company, N.A., and Point72 Asset Management, L.P..
This page lists
96
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.